Metraipolis › archive › dc_fb178cdcde48

Sestrin3 confers resistance to recombinant human arginase in small cell lung cancer by activating Akt/mTOR/ASS1 axis — Europe PMC PMID:41460862

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41460862
DOI: 10.1371/journal.pone.0338802
License (as archived): solo-consultazione
Archived: 2026-11-07T08:53:11.906Z
SHA-256 of the archived text: b7348c110de1799eeb8f622c373e54564d7b65b5c5776ea6b450fa7036c7d136
Stable URL of this page: https://metraipolis.com/documento/dc_fb178cdcde48

How to cite

Sestrin3 confers resistance to recombinant human arginase in small cell lung cancer by activating Akt/mTOR/ASS1 axis — Europe PMC PMID:41460862 — Europe PMC (en), https://europepmc.org/article/MED/41460862 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb178cdcde48 (Metraipolis archive dc_fb178cdcde48, sha256 b7348c110de1799eeb8f622c373e54564d7b65b5c5776ea6b450fa7036c7d136)

BibTeX

@misc{dcfb178cdcde48,
  title = {Sestrin3 confers resistance to recombinant human arginase in small cell lung cancer by activating Akt/mTOR/ASS1 axis — Europe PMC PMID:41460862},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41460862},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb178cdcde48; sha256 b7348c110de1799eeb8f622c373e54564d7b65b5c5776ea6b450fa7036c7d136},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41460862. Agents can read the archived copy with the MCP tool read_document.